These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32454654)

  • 1. Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy.
    Naraparaju S; Anumolu PKD; Gurrala S; Galennagari R
    Turk J Pharm Sci; 2018 Aug; 15(2):149-155. PubMed ID: 32454654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micellar-enhanced and green-assessed first-derivative synchronous spectrofluorimetric approach for concurrent determination of alfuzosin hydrochloride and solifenacin succinate in different matrices: Docking simulation.
    Sayed RA; Mohamed AR; Shalaby A; Ibrahim H
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 May; 293():122442. PubMed ID: 36758367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart UV spectrophotometric methods based on simple mathematical filtration and classical methods for the simultaneous determination of tamsulosin and solifenacin: A comparative study of efficacy and spectral resolution.
    El-Henawee MM; Abd El-Hay SS; Attala K; Eissa MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Feb; 247():119151. PubMed ID: 33188970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Synchronous Fluorescence Spectrofluorometric Method for the Simultaneous Determination of Clonazepam and Paroxetine Hydrochloride in Combined Pharmaceutical Dose Form.
    Patel JU; Chhalotiya UK; Shah PA
    Turk J Pharm Sci; 2017 Dec; 14(3):251-256. PubMed ID: 32454621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of new combination of tamsulosin and tadalafil using synchronous spectrofluorimetric method coupled with mathematical tools.
    M Youssef R; Abdelhafez AM; Hassan EM; Gawad DA
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Apr; 271():120904. PubMed ID: 35104741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourier convolution versus derivative spectrophotometry: Application to the analysis of two binary mixtures containing tamsulosin hydrochloride as a minor component.
    El-Kimary EI; Khamis EF; Belal SF; Abdel Moneim MM
    Ann Pharm Fr; 2020 Mar; 78(2):129-141. PubMed ID: 32070480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two green chromatographic methods for the quantification of tamsulosin and solifenacin along with four of their impurities.
    Kamel EB
    J Sep Sci; 2022 Apr; 45(7):1305-1316. PubMed ID: 35084111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride.
    El-Kimary EI; Khamis EF; Belal SF; Abdel Moneim MM
    Luminescence; 2018 Jun; 33(4):771-779. PubMed ID: 29578287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Effect by Co-Administration of Tamsulosin and Solifenacin on Bladder Activity in Rats.
    Nishijima S; Sugaya K; Kadekawa K; Ashitomi K; Ohtake A; Sasamata M; Yamamoto H
    Low Urin Tract Symptoms; 2012 Jan; 4(1):3-8. PubMed ID: 26676451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green & Sensitive pH-dependent Spectrofluorimetric Assay of Tamsulosin Hydrochloride and Tadalafil in their New Combined Formulation for Benign Prostatic Hyperplasia: Application to Spiked Human Plasma.
    Abdel Moneim MM
    J Fluoresc; 2022 Jul; 32(4):1581-1590. PubMed ID: 35576092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Nazir J; Heemstra L; van Engen A; Hakimi Z; Ivanescu C
    BMC Urol; 2015 May; 15():41. PubMed ID: 25956727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
    Shin YS; Zhang LT; You JH; Choi IS; Zhao C; Park JK
    Clin Interv Aging; 2016; 11():1301-1307. PubMed ID: 27698559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
    Sahin A; Yildirim C; Yuksel OH; Urkmez A
    Arch Esp Urol; 2020 Jan; 73(1):54-59. PubMed ID: 31950924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric estimation of solifenacin succinate in tablet formulations.
    Singh L; Nanda S
    Pharm Methods; 2011 Jan; 2(1):21-4. PubMed ID: 23781425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
    Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
    World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms.
    Romancik M; Pandian S; Drake MJ
    Drugs Today (Barc); 2014 Dec; 50(12):803-11. PubMed ID: 25588085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-derivative synchronous spectrofluorimetric determination of nebivolol hydrochloride and amlodipine besylate in their combined dosage form.
    Ibrahim F; El-Enany N; Shalan SH; Abo Shabana RA
    Luminescence; 2015 Nov; 30(7):1011-9. PubMed ID: 25727077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage.
    Kosilov K; Kuzina I; Kuznetsov V; Gainullina Y; Kosilova L; Prokofyeva A; Loparev S
    Aging Male; 2018 Jun; 21(2):121-129. PubMed ID: 29113548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous derivative spectrophotometric analysis of doxylamine succinate, pyridoxine hydrochloride and folic Acid in combined dosage forms.
    Pathak A; Rajput SJ
    Indian J Pharm Sci; 2008; 70(4):513-7. PubMed ID: 20046784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.